Richard S. Levy, EVP, Chief Drug Development Officer at INCYTE CORP (INCY), sold 3,937 shares at $101.86 ($401K) on 2016-01-06, disclosed to the SEC on 2016-01-08.
Open-market sale of $401k INCY by EVP, Chief Drug Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |